Net Cash Provided by (Used in) Financing Activities of Pulmonx Corp from 31 Dec 2018 to 31 Dec 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Pulmonx Corp annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2018 to 31 Dec 2025.
  • Pulmonx Corp Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $664,000, a 23% decline year-over-year.
  • Pulmonx Corp annual Net Cash Provided by (Used in) Financing Activities for 2025 was $833,000, a 39% decline from 2024.
  • Pulmonx Corp annual Net Cash Provided by (Used in) Financing Activities for 2024 was $1,363,000, a 94% decline from 2023.
  • Pulmonx Corp annual Net Cash Provided by (Used in) Financing Activities for 2023 was $21,400,000, a 785% increase from 2022.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Change (%)
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Change (%)

Pulmonx Corp Annual Net Cash Provided by (Used in) Financing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2025 $833,000 -$530,000 -39% 01 Jan 2025 31 Dec 2025 10-K 10 Mar 2026 2025 FY
2024 $1,363,000 -$20,037,000 -94% 01 Jan 2024 31 Dec 2024 10-K 10 Mar 2026 2025 FY
2023 $21,400,000 +$18,981,000 +785% 01 Jan 2023 31 Dec 2023 10-K 25 Feb 2025 2024 FY
2022 $2,419,000 -$2,037,000 -46% 01 Jan 2022 31 Dec 2022 10-K 27 Feb 2024 2023 FY
2021 $4,456,000 -$230,375,000 -98% 01 Jan 2021 31 Dec 2021 10-K 01 Mar 2023 2022 FY
2020 $234,831,000 +$189,212,000 +415% 01 Jan 2020 31 Dec 2020 10-K 01 Mar 2022 2021 FY
2019 $45,619,000 +$33,505,000 +277% 01 Jan 2019 31 Dec 2019 10-K 15 Mar 2021 2020 FY
2018 $12,114,000 01 Jan 2018 31 Dec 2018 10-K 15 Mar 2021 2020 FY

Pulmonx Corp Quarterly Net Cash Provided by (Used in) Financing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $664,000 -$200,000 -23% 01 Jan 2025 31 Mar 2025 10-Q 02 May 2025 2025 Q1
Q1 2024 $864,000 -$19,856,000 -96% 01 Jan 2024 31 Mar 2024 10-Q 02 May 2025 2025 Q1
Q1 2023 $20,720,000 +$19,405,000 +1476% 01 Jan 2023 31 Mar 2023 10-Q 03 May 2024 2024 Q1
Q1 2022 $1,315,000 +$1,302,000 +10015% 01 Jan 2022 31 Mar 2022 10-Q 08 May 2023 2023 Q1
Q1 2021 $13,000 -$1,295,000 -99% 01 Jan 2021 31 Mar 2021 10-Q 09 May 2022 2022 Q1
Q1 2020 $1,308,000 01 Jan 2020 31 Mar 2020 10-Q 12 May 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.